FIFTH AMENDMENT TO AGREEMENTResearch Collaboration and License Agreement • June 18th, 2008 • Celera CORP • Services-commercial physical & biological research
Contract Type FiledJune 18th, 2008 Company IndustryThis is the fifth amendment to the Research Collaboration and License Agreement between MERCK & CO., INC., a corporation organized and existing under the laws of New Jersey (“MERCK”) and ARRIS PHARMACEUTICAL CORPORATION, a corporation organized and existing under the laws of Delaware, now known as Axys Pharmaceuticals, Inc- (“Axys”) made as of November 6, 1996 (the “Agreement”). The purpose of this fifth amendment is to extend the research term of the collaboration through November 5, 2001.
FIFTH AMENDMENT TO AGREEMENTResearch Collaboration and License Agreement • June 16th, 2008 • Celera CORP • Services-commercial physical & biological research
Contract Type FiledJune 16th, 2008 Company IndustryThis is the fifth amendment to the Research Collaboration and License Agreement between MERCK & CO., INC., a corporation organized and existing under the laws of New Jersey (“MERCK”) and ARRIS PHARMACEUTICAL CORPORATION, a corporation organized and existing under the laws of Delaware, now known as Axys Pharmaceuticals, Inc- (“Axys”) made as of November 6, 1996 (the “Agreement”). The purpose of this fifth amendment is to extend the research term of the collaboration through November 5, 2001.